Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYAptose to Present New Preclinical Data for CG-806 at the 24th Congress of The European Hematology AssociationPREV STORYInnovation Pharmaceuticals Announces Non-Binding Term Sheet Signed with Global Pharmaceutical Company to Develop and Commercialize Brilacidin for the Treatment of Ulcerative Proctitis/Ulcerative Proctosigmoiditis